|
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
|
№9 / 2017
|
|
I.A. Zolotovskaya (1), I.L. Davydkin (1), N.Yu. Borovkova (2)
THERAPY WITH NONSTEROID ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ACUTE NONSPECIFIC LOW BACK PAIN: DYNAMICS OF RENAL FUNCTION: RESULTS OF “PANDA” COGORT STUDY
|
№7 / 2017
|
|
I.T. Murkamilov (1), K.A. Aytbaev (2), F.A. Yusupov (3)
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
|
№5 / 2017
|
|
E.V. Biryukova
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
|
№5 / 2017
|
|
N.A. Demidov (1), M.B. Antsiferov (2), L.G. Dorofeeva (2)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
|
№5 / 2017
|
|
M.B. Antsiferov
FEATURES OF USE OF DAPAGLIFLOZIN IN THETREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№16 / 2016
|
|
M.B. Antsiferov
CLINICAL CHARACTERISTICS AND PRACTICAL ASPECTS OF THE USE OF NEW BASAL INSULIN GLARGINE 300 U/ ML TOUJEO SOLOSTAR®
|
№16 / 2016
|
|
A.F. Verbovoy, L.A. Sharonova
DIABETES MELLITUS AND CORONARY ARTERY DISEASE: FEATURES OF CLINICAL MANIFESTATION AND TREATMENT.
|
№16 / 2016
|
|
L.V. Egshatyan (1), A.M. Mkrtumyan (1), L.A. Zvenigorodskaya (2)
METABOLIC SYNDROME AND INTESTINAL MICROBIOTA
|
№16 / 2016
|
|
A.V. Tolkushin
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
|
№5 / 2016
|
|
O.L. Badalyan, A.A. Savenkov
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
|
№5 / 2016
|
|
D.V. Kurkin, E.V. Volotova, D.A. Bakulin, E.M. Lomkina, I.N. Tyurenkov
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
|
№5 / 2016
|
Русский
